牛叉诊股

[{"date":"2026.11.13","stock":"-3.41","trade":"-1.88","ind":"-2.05"},{"date":"2026.11.12","stock":"2.47","trade":"-0.19","ind":"-1.68"},{"date":"2026.11.11","stock":"1.11","trade":"-0.53","ind":"1.32"},{"date":"2026.11.10","stock":"1.98","trade":"0.88","ind":"0.86"},{"date":"2026.11.09","stock":"-2.68","trade":"-0.20","ind":"-0.27"},{"date":"2026.11.06","stock":"-2.02","trade":"-0.80","ind":"-2.57"},{"date":"2026.11.05","stock":"3.20","trade":"1.29","ind":"1.19"},{"date":"2026.11.04","stock":"1.41","trade":"0.85","ind":"4.22"},{"date":"2026.11.03","stock":"-1.18","trade":"0.44","ind":"-1.21"},{"date":"2026.11.02","stock":"3.38","trade":"1.93","ind":"1.63"},{"date":"2026.10.30","stock":"-2.18","trade":"-0.03","ind":"-2.73"},{"date":"2026.10.29","stock":"-3.79","trade":"-1.62","ind":"-2.92"},{"date":"2026.10.28","stock":"0.07","trade":"0.86","ind":"2.02"},{"date":"2026.10.27","stock":"-4.78","trade":"-2.32","ind":"-2.50"},{"date":"2026.10.26","stock":"3.06","trade":"0.48","ind":"-1.19"},{"date":"2026.10.23","stock":"8.83","trade":"0.88","ind":"2.79"},{"date":"2026.10.22","stock":"-3.70","trade":"-2.52","ind":"-2.96"},{"date":"2026.10.21","stock":"-0.62","trade":"-0.15","ind":"-0.82"},{"date":"2026.10.20","stock":"0.84","trade":"-0.28","ind":"-0.14"},{"date":"2026.10.19","stock":"-2.05","trade":"0.26","ind":"0.13"},{"date":"2026.10.16","stock":"1.53","trade":"-0.12","ind":"-0.12"}]

新光药业,深证成指,中药指数

压力支撑

该股压力位为14.61元，支撑位为14.22元。

[{"text":"\u538b\u529b\u4f4d","value":"14.61","date":1794499200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.22","date":1794499200,"color":"0x0b52a1"}]

多空趋势

空头行情中，并且有加速下跌的趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.2资金面打败了25%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：11月13日 20:30

机构今日流向(万元)	-1676.34	机构5日流向(万元)	-6423.53
机构10日流向(万元)	-3790.27	机构20日流向(万元)	-6988.91

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量减少24.15万股，其中基金数没有增加，主力净增仓52家，暂未发现中长期投资价值。

截止2026-06-30，共90家主力机构（基金89家，一般法人1家），持仓量总计2639.26万股，占流通A股23.13%
其中，基金持仓与2025-12-31相比：
增仓：10家，增持 113.83万股
减仓：10家，减持 28.94万股
新出现在主力名单中：67家，持有400.22万股
从主力名单中消失：15家，原持有87.15万股

消息面诊股

诊断结果：5.5消息面打败了35%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	分红转增	不分配不转增	2026-08-25
利好	重大事项	参股拟上市公司或非上市公司金融机构	2026-06-30
一般消息	股东大会	年度股东大会	2026-04-21
利好	分红转增	10派3元(含税)	2026-04-21
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	0条	0条	0条

行业面诊股

诊断结果：3.3行业面打败了21%的股票中药行业最新资金流向

近10日来该行业走势不明显，接近大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2026.11.13","price":"-2.05","value":"-1.88"},{"date":"2026.11.12","price":"-1.68","value":"-0.19"},{"date":"2026.11.11","price":"1.32","value":"-0.53"},{"date":"2026.11.10","price":"0.86","value":"0.88"},{"date":"2026.11.09","price":"-0.27","value":"-0.20"},{"date":"2026.11.06","price":"-2.57","value":"-0.80"},{"date":"2026.11.05","price":"1.19","value":"1.29"},{"date":"2026.11.04","price":"4.22","value":"0.85"},{"date":"2026.11.03","price":"-1.21","value":"0.44"},{"date":"2026.11.02","price":"1.63","value":"1.93"},{"date":"2026.10.30","price":"-2.73","value":"-0.03"},{"date":"2026.10.29","price":"-2.92","value":"-1.62"},{"date":"2026.10.28","price":"2.02","value":"0.86"},{"date":"2026.10.27","price":"-2.50","value":"-2.32"},{"date":"2026.10.26","price":"-1.19","value":"0.48"},{"date":"2026.10.23","price":"2.79","value":"0.88"},{"date":"2026.10.22","price":"-2.96","value":"-2.52"},{"date":"2026.10.21","price":"-0.82","value":"-0.15"},{"date":"2026.10.20","price":"-0.14","value":"-0.28"},{"date":"2026.10.19","price":"0.13","value":"0.26"},{"date":"2026.10.16","price":"-0.12","value":"-0.12"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	维康药业	19.82%	6.81%	6.0分
2	桂林三金	18.87%	-20.44%	5.6分
3	*ST香雪	18.68%	20.08%	5.7分
4	恩威医药	16.18%	10.05%	6.1分
5	济川药业	15.47%	2.46%	7.0分
6	盘龙药业	10.29%	9.63%	5.5分
7	羚锐制药	8.07%	-4.65%	6.7分
8	片仔癀	8.00%	-4.12%	5.7分
9	达仁堂	6.59%	-5.86%	5.1分
10	东阿阿胶	6.19%	-0.79%	6.6分
11	葵花药业	5.73%	-2.15%	5.1分
12	步长制药	4.34%	-2.98%	5.6分
13	云南白药	4.03%	0.15%	6.6分
14	信邦制药	2.81%	-3.93%	5.3分
15	以岭药业	2.12%	-4.17%	5.3分
16	马应龙	1.30%	-0.64%	6.2分
17	天士力	-0.43%	-2.85%	5.9分
18	华润三九	-0.47%	-1.93%	6.3分
19	昆药集团	-0.48%	-5.64%	4.8分
20	康美药业	-0.77%	-3.73%	5.0分
21	新光药业	-1.10%	-0.69%	4.8分
22	亚宝药业	-1.17%	-1.31%	4.8分
23	健民集团	-1.21%	-3.19%	5.9分
24	华润江中	-1.65%	-2.54%	6.1分
25	吉林敖东	-1.78%	-3.49%	4.6分
26	同仁堂	-2.38%	-7.22%	4.7分
27	康缘药业	-2.59%	-5.50%	5.2分
28	白云山	-2.96%	-3.68%	5.1分
29	众生药业	-3.06%	3.13%	5.8分
30	奇正藏药	-3.29%	-4.34%	4.9分
31	康恩贝	-3.51%	-3.29%	4.9分
32	仁和药业	-3.74%	-3.55%	4.7分
33	方盛制药	-4.06%	-5.00%	5.0分
34	九芝堂	-4.75%	-1.91%	6.0分
35	-	-4.93%	-0.93%	分
36	红日药业	-5.00%	-5.59%	4.4分
37	-	-5.01%	-0.62%	分
38	ST葫芦娃	-5.19%	-1.12%	5.1分
39	太极集团	-5.30%	-6.73%	5.1分
40	陇神戎发	-5.37%	3.44%	5.2分
41	寿仙谷	-5.46%	-1.53%	4.7分
42	特一药业	-5.49%	1.11%	5.5分
43	ST百灵	-6.19%	-4.29%	3.8分
44	ST嘉应	-6.27%	-1.57%	5.1分
45	珍宝岛	-6.55%	-5.99%	5.2分
46	新天药业	-6.58%	-0.26%	5.0分
47	千金药业	-6.74%	-2.72%	5.5分
48	三力制药	-6.84%	-3.23%	5.1分
49	振东制药	-7.54%	-2.71%	5.0分
50	上海凯宝	-7.75%	-3.73%	4.6分
51	汉森制药	-7.88%	-1.43%	5.4分
52	佛慈制药	-7.90%	-3.42%	5.3分
53	佐力药业	-8.16%	-3.75%	5.1分
54	沃华医药	-8.98%	-1.84%	5.7分
55	益佰制药	-9.28%	-2.19%	4.4分
56	ST金花	-9.50%	-4.27%	4.7分
57	太龙药业	-10.81%	-2.01%	4.7分
58	华森制药	-10.84%	0.46%	5.2分
59	华神科技	-11.28%	-0.56%	5.2分
60	古汉医药	-11.76%	-0.76%	4.6分
61	粤万年青	-11.83%	2.63%	5.2分
62	中恒集团	-12.60%	-1.83%	4.8分
63	广誉远	-12.77%	-5.03%	4.8分
64	益盛药业	-12.85%	-1.65%	4.9分
65	精华制药	-14.91%	-1.30%	4.8分
66	ST万邦	-15.12%	-2.01%	5.2分
67	康惠股份	-17.03%	-2.26%	5.3分
68	天目药业	-17.04%	-5.97%	4.8分

<上一页 1 2 3 4 5...12 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.3基本面打败了66%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值一般。

个股深一度

潜在高分红能力：弱（80分）

基本面得分最高的股票

[ 截止日期：2026-09-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/110 ， 40/110。

[{"date":"2026-09-30","value":"7.58","vol":"4.23"},{"date":"2026-06-30","value":"4.77","vol":"3.25"},{"date":"2026-03-31","value":"3.10","vol":"2.21"},{"date":"2025-12-31","value":"6.50","vol":"-2.33"},{"date":"2025-09-30","value":"5.47","vol":"4.80"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
净资产收益率(%)	7.58	4.77	3.10	6.50	5.47
行业(%)	4.23	3.25	2.21	-2.33	4.80

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"50.29","vol":"52.92"},{"date":"2026-06-30","value":"46.06","vol":"53.70"},{"date":"2026-03-31","value":"45.37","vol":"55.05"},{"date":"2025-12-31","value":"38.76","vol":"52.85"},{"date":"2025-09-30","value":"39.12","vol":"53.29"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
销售毛利率(%)	50.29	46.06	45.37	38.76	39.12
行业(%)	52.92	53.70	55.05	52.85	53.29

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 16/110 ， 11/110。

[{"date":"2026-09-30","value":"2.60","vol":"-8.01"},{"date":"2026-06-30","value":"1.17","vol":"-9.08"},{"date":"2026-03-31","value":"-5.13","vol":"-5.58"},{"date":"2025-12-31","value":"-0.86","vol":"-6.76"},{"date":"2025-09-30","value":"-4.90","vol":"-7.84"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
营业收入同比增长率(%)	2.60	1.17	-5.13	-0.86	-4.90
行业(%)	-8.01	-9.08	-5.58	-6.76	-7.84

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"41.39","vol":"-22.29"},{"date":"2026-06-30","value":"24.46","vol":"-101.51"},{"date":"2026-03-31","value":"7.44","vol":"1.06"},{"date":"2025-12-31","value":"7.58","vol":"-80.25"},{"date":"2025-09-30","value":"19.99","vol":"-2.78"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
净利润同比增长率(%)	41.39	24.46	7.44	7.58	19.99
行业(%)	-22.29	-101.51	1.06	-80.25	-2.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 52/110 ， 10/110。

[{"date":"2026-09-30","value":"0.23","vol":"0.33"},{"date":"2026-06-30","value":"0.16","vol":"0.22"},{"date":"2026-03-31","value":"0.10","vol":"0.12"},{"date":"2025-12-31","value":"0.29","vol":"0.47"},{"date":"2025-09-30","value":"0.23","vol":"0.35"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
总资产周转率(次)	0.23	0.16	0.10	0.29	0.23
行业(次)	0.33	0.22	0.12	0.47	0.35

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"2.67","vol":"1.72"},{"date":"2026-06-30","value":"2.13","vol":"1.14"},{"date":"2026-03-31","value":"1.39","vol":"0.59"},{"date":"2025-12-31","value":"2.89","vol":"2.34"},{"date":"2025-09-30","value":"1.93","vol":"1.72"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
存货增长率(次)	2.67	2.13	1.39	2.89	1.93
行业(次)	1.72	1.14	0.59	2.34	1.72

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-09-30","value":"24.02","vol":"13.37"},{"date":"2026-06-30","value":"11.04","vol":"20.65"},{"date":"2026-03-31","value":"58.56","vol":"5.83"},{"date":"2025-12-31","value":"30.69","vol":"30.77"},{"date":"2025-09-30","value":"21.28","vol":"10.53"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
现金流量净额/营业收入	24.02	11.04	58.56	30.69	21.28
行业	13.37	20.65	5.83	30.77	10.53

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.03","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.24","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
资本支出／折旧和摊销	-	0.03	-	0.24	-
行业	0.00	0.88	0.00	1.00	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 66/110 ， 66/110。

[{"date":"2026-09-30","value":"16.45","vol":"3.18"},{"date":"2026-06-30","value":"16.76","vol":"3.10"},{"date":"2026-03-31","value":"16.38","vol":"2.97"},{"date":"2025-12-31","value":"17.16","vol":"2.94"},{"date":"2025-09-30","value":"13.41","vol":"3.09"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
流动比率	16.45	16.76	16.38	17.16	13.41
行业	3.18	3.10	2.97	2.94	3.09

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"15.68","vol":"2.39"},{"date":"2026-06-30","value":"16.11","vol":"2.34"},{"date":"2026-03-31","value":"15.80","vol":"2.23"},{"date":"2025-12-31","value":"16.17","vol":"2.15"},{"date":"2025-09-30","value":"12.31","vol":"2.24"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
速动比率	15.68	16.11	15.80	16.17	12.31
行业	2.39	2.34	2.23	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 64/110 ， 64/110。

[{"date":"2026-09-30","value":"6.13","vol":"31.42"},{"date":"2026-06-30","value":"6.05","vol":"32.07"},{"date":"2026-03-31","value":"6.18","vol":"31.94"},{"date":"2025-12-31","value":"5.91","vol":"32.43"},{"date":"2025-09-30","value":"7.33","vol":"31.59"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
资产负债率(%)	6.13	6.05	6.18	5.91	7.33
行业(%)	31.42	32.07	31.94	32.43	31.59

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"0.07","vol":"0.67"},{"date":"2026-06-30","value":"0.06","vol":"0.68"},{"date":"2026-03-31","value":"0.07","vol":"0.66"},{"date":"2025-12-31","value":"0.06","vol":"0.67"},{"date":"2025-09-30","value":"0.08","vol":"0.76"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
产权比率 (%)	0.07	0.06	0.07	0.06	0.08
行业(%)	0.67	0.68	0.66	0.67	0.76

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"1.09","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.64","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.50","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.54","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[新光药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]